Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-389.78%EBITDA Margin
VS
Market
Sector
Industry
History
$ 4.29Close
$ 2.32 - $ 281.25 52-Week Range
Ticker Information
Ticker
BNBXCompany Name
APPLIED DNA SCIENCES INCSector
HealthcareIndustry
Diagnostics & ResearchExchange
NASDAQAPPLIED DNA SCIENCES INC - EBITDA Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
BNBX - EBITDA % Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ -12.85M | -389.78% | $ 3.3M |
| 3/31/2025 | $ -6.97M | -183.93% | $ 3.79M |
| 12/31/2024 | $ -8.07M | -215.98% | $ 3.74M |
| 9/30/2024 | $ -6.3M | -183.48% | $ 3.43M |
| 6/30/2024 | $ -6.34M | -186.55% | $ 3.4M |
| 3/31/2024 | $ -11.1M | -201.23% | $ 5.52M |
| 12/31/2023 | $ -5.89M | -65.44% | $ 9M |
| 9/30/2023 | $ -8.58M | -64.22% | $ 13.37M |
| 6/30/2023 | $ -5.67M | -35.11% | $ 16.15M |
| 3/31/2023 | $ -3.72M | -21.23% | $ 17.53M |
Key Performance Insights, Last 5 Years
- APPLIED DNA SCIENCES INC's latest trailing twelve months (TTM) EBITDA % stands at -653.67%.
- Over the past 5 years, APPLIED DNA SCIENCES INC's average EBITDA % has been -183.18%.
- The median EBITDA % for APPLIED DNA SCIENCES INC during this period was -166.27%
- APPLIED DNA SCIENCES INC reached its highest EBITDA % over the past 5 years at -21.23%.
- The lowest EBITDA % recorded by APPLIED DNA SCIENCES INC in the same timeframe -653.67%
APPLIED DNA SCIENCES INC's EBITDA % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA % Benchmarks
Similar metrics to Revenues:
- EBIT Margin - [Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Free Cash Flow Margin - [Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
Definition of EBITDA Margin
[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.EBITDA / Revenues
(=) EBITDA % EBITDA % for APPLIED DNA SCIENCES INC is calculated as follows: EBITDA [ $ -12.63M ] / Revenues [ $ 1.93M ]
(=) EBITDA % [ -653.67% ] BNBX - EBITDA Margin, Last 5 years
-653.67%
Minimum
Sep 30, 2020
-21.23%
Maximum
Mar 31, 2023
-183.18%
Average
-166.27%
Median
EBITDA % Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.2% with a standard deviation of 26.73%.
The following table provides additional summary stats:
EBITDA % in the Market:
| filtered constituents | 3.29K |
|---|---|
| min | -74.33% |
| max | 97.24% |
| average | 16.2% |
| median | 14.74% |
| std | 26.73% |